Postprandial Blood Glucose Control With BioChaperone Combo and Insulin Lispro (Humalog) Mix 25 in People With Type 1 Diabetes Mellitus
Phase of Trial: Phase I
Latest Information Update: 16 Sep 2016
At a glance
- Drugs Insulin glargine/insulin lispro (Primary) ; Insulin neutral protamine lispro/insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Adocia
- 16 Sep 2016 Results assessing post-prandial glucose in type 1 diabetes patients, presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes.
- 08 Sep 2016 According to an Adocia media release, data from this trial were presented at the 52nd European Association for the Study of Diabetes (EASD) Annual Meeting, 2016.
- 06 Jun 2016 Results will be presented at the American Diabetes Association 76th Scientific Sessions 2016, according to an Adocia media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History